Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT

Abattis Bioceuticals Company Description

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada.

The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets.

It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry.

The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012.

Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Abattis Bioceuticals Corp.
Abattis Bioceuticals logo
Country Canada
Founded 1997
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare

Contact Details

Address:
625 Howe Street
Vancouver, British Columbia V6C 2M6
Canada
Phone 808 650 3007
Website abattis.com

Stock Details

Ticker Symbol ATTBF
Exchange OTCMKTS
Fiscal Year October - September
Reporting Currency CAD
ISIN Number CA00258G1037
SIC Code 2834

Key Executives

Name Position
Francesco Paolini Chief Financial Officer and Director
Patrick Mitchell Chief Operating Officer and Director
Shawn Balaghi Head of Corporate Development
Jim Carter Head of Mergers and Acquisitions Advisory
Christopher P. Cherry C.A., CPA, CGA Corporate Comptroller
Nicole Breitinger Corporate Secretary